Table 3.
Secondary outcomes regarding VAS scores for resting pain
| Time after surgery | Duloxetine* (n = 48) | Placebo* (n = 48) | P value† |
|---|---|---|---|
| 3 h | 4.1 ± 1.0 | 4.5 ± 1.1 | 0.026 |
| 6 h | 4.0 ± 1.0 | 4.4 ± 1.0 | 0.032 |
| 12 h | 3.3 ± 1.0 | 3.8 ± 1.1 | 0.044 |
| 24 h | 3.0 ± 1.1 | 3.5 ± 1.1 | 0.046 |
| 48 h | 2.3 ± 1.0 | 2.8 ± 1.0 | 0.019 |
| 72 h | 1.8 ± 0.9 | 2.2 ± 1.0 | 0.023 |
| 1w | 1.0 ± 0.8 | 1.3 ± 0.8 | 0.040 |
| 3w | 0.8 ± 0.7 | 1.1 ± 0.7 | 0.043 |
| 3 m | 0.6 ± 0.5 | 0.7 ± 0.6 | 0.851 |
*The values are given as the mean and standard deviation. †P values are calculated by independent t-test. P values indicating a significant difference among groups are in bold